Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$9.45 -0.86 (-8.34%)
As of: Nov 12, 2026 · 2:14 PM EST

Monte Rosa Therapeutics (GLUE) Sales of Property, Plant and Equipment (2021 - 2023)

Updated

Monte Rosa Therapeutics' Sales of Property, Plant and Equipment was $62,000 in FY2023, down 43.1% from $109,000 in FY2022.

Analysis

Monte Rosa Therapeutics (GLUE) Sales of Property, Plant and Equipment (2021 - 2023) Analysis & Trends

  • Per Business Quant data, Sales of Property, Plant and Equipment in earlier years was $109,000 in FY2022 (+38.0%) and $79,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Monte Rosa Therapeutics 897.23 Mn 472.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 62,000.00
Sep 30, 2022 -16,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 12,000.00
API Access

Monte Rosa Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=GLUE&period=max&api_key=YOUR_API_KEY